These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8859942)

  • 21. Central cardiovascular effects of rilmenidine and neuropeptide Y in the conscious spontaneously hypertensive rat: haemodynamic and biochemical evidence for a negative interaction.
    McAuley MA; Reid JL; Macrae IM
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):945-52. PubMed ID: 1376817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action.
    Yokosuka M; Kalra PS; Kalra SP
    Endocrinology; 1999 Oct; 140(10):4494-500. PubMed ID: 10499503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
    Allen AR; Kelso EJ; Bell D; Zhao Y; Dickson P; McDermott BJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1286-96. PubMed ID: 16973886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats.
    Ishihara A; Tanaka T; Kanatani A; Fukami T; Ihara M; Fukuroda T
    Am J Physiol; 1998 May; 274(5):R1500-4. PubMed ID: 9612420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP.
    Nakamura K; Sasaki S; Moriguchi J; Morimoto S; Miki S; Kawa T; Itoh H; Nakata T; Takeda K; Nakagawa M
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):876-82. PubMed ID: 10367590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
    Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
    J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of neuropeptide Y in cold stress-induced hypertension.
    Han S; Chen X; Cox B; Yang CL; Wu YM; Naes L; Westfall T
    Peptides; 1998; 19(2):351-8. PubMed ID: 9493868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of neuropeptide Y in the development of two-kidney, one-clip renovascular hypertension in the rat.
    Shin LH; Dovgan PS; Nypaver TJ; Carretero OA; Beierwaltes WH
    J Vasc Surg; 2000 Nov; 32(5):1015-21. PubMed ID: 11054234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
    DiBona GF; Sawin LL
    J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in blood pressure of normotensive and hypertensive rats following intrathecal injections of neuropeptide Y.
    Chen X; Henderson K; Beinfeld MC; Westfall TC
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):473-8. PubMed ID: 2465449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of bradykinin and icatibant on renal hemodynamics in conscious spontaneously hypertensive and normotensive rats.
    Braun C; Ade M; Unger T; van der Woude FJ; Rohmeiss P
    J Cardiovasc Pharmacol; 1997 Oct; 30(4):446-54. PubMed ID: 9335403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y.
    Kask A; Rägo L; Korrovits P; Wikberg JE; Schiöth HB
    Biochem Biophys Res Commun; 1998 Jul; 248(2):245-9. PubMed ID: 9675121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
    Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic pressor action of neuropeptide Y and norepinephrine in conscious rats.
    Itoi K; Mouri T; Takahashi K; Sasaki S; Imai Y; Yoshinaga K
    J Hypertens Suppl; 1986 Dec; 4(6):S247-50. PubMed ID: 3475412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
    Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
    J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic profile of neuropeptide Y in dogs: effect of ganglionic blockade.
    Hashim MA; Harrington WW; Daniels AJ; Tadepalli AS
    Peptides; 1997; 18(2):235-9. PubMed ID: 9149295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test.
    Kask A; Rägo L; Harro J
    Neuroreport; 1998 Aug; 9(12):2713-6. PubMed ID: 9760107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.